Drugs / Tranexamic Acid (TXA)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03063892 | Aug 2017 → Jul 2027 expected | — | Gregory M Georgiadis MD | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tranexamic Acid (TXA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03063892 ↗ |
| Route | Intravenous | “intravenous Tranexamic Acid (TXA) 15mg/kg (maximum 1 gram) bolus dose over 10 minutes” NCT03063892 ↗ |